发明公开
- 专利标题： Dosages for treatment of anti-erbB2 antibodies
- 专利标题（中）： 治疗抗erbB2抗体的剂量
-
申请号： EP09008313.0申请日： 2000-08-25
-
公开(公告)号： EP2111870A1公开(公告)日： 2009-10-28
- 发明人: Baughman, Sharon, Ann , Shak, Steven
- 申请人： Genentech, Inc.
- 申请人地址： 1 DNA Way South San Francisco CA 94080-4990 US
- 专利权人： Genentech, Inc.
- 当前专利权人： Genentech, Inc.
- 当前专利权人地址： 1 DNA Way South San Francisco CA 94080-4990 US
- 代理机构： Walton, Seán Malcolm
- 优先权： US151018P 19990827; US213822P 20000623
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K16/32
摘要：
The present invention concerns the treatment of disorders characterized by the overexpression of ErbB2. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with anti-ErbB2 antibody.
信息查询
